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Abstract.  
Background: Diabetes Mellitus (DM) – is one of the most common chronic diseases, and its control is 
affected by the patients' psychological attributes (Esmaeilinasab et al., 2016).  The number of patients with 
this disease is expected to increase in future. Given the increasing prevalence of DM, there is an urgent need 
for the treatment of DM and associated complications. Glycemic control largely depends on compliance 
with medication therapy. In fact, the most common problem in patients with DM – is a lack of medication 
compliance (Shamsi, Khodaifar, Arzaghi, Sarvghadi, Ghazi, 2014). For example, laboratory data of single 
components of the metabolic syndrome, according to International Diabetes Federation Consensus were 
dependent measures in multivariable regression models with self-reported alexithymia severity (TAS-20) 
and socio-demographic data. Alexithymia is a clinical trait, consisting of diminished introspective and 
interoceptive capacities that have been shown to implicate elevated autonomic outflow and to bias for 
hypertension (Lemche, Chaban, Lemche, 2014). One of the challenges in promoting adherence to 
medication regimes is having an accurate understanding of adherence rates and the factors that contribute to 
non-adherence (Lehmann et al., 2014). It's essential to consider the clinical assessment of psychological 
aspects in patients with DM, in order to prevent potentially adverse self-care management behaviours 
leading to diabetes-related complications, including declining levels of life quality (Conti et al., 2017). The 
patient`s quality of life is one of the principal components in clinical decision-making (Chaban, Khaustova, 
Bezsheiko, n.d.). 
Purpose: Improving the effectiveness of DM patients therapy and demonstrating the consequence of 
psychosocial factors on their adherence to treatment. 
Method: This study was conducted during the period from July to August 2017 on the basis of the Kyiv 
Endocrinology Centre and the Department of Endocrinology in partnership with the Department of Medical 
Psychology, Psychosomatic Medicine and Psychotherapy of the Bogomolets National Medical University. 
Study population (n=60) consisted of two comparative groups (CG) of patients with DM type 1 (DM1) 
(n=16) and type 2 (DM2) (n=33), while other patients had newly diagnosed DM of both DM1 and DM2. 
Study data consists of: hospital chart data (age, demographic data, body mass index, level of systolic and 
diastolic arterial pressure, blood glucose and glycated hemoglobin (HbA1c); psychometric validated scales ( 
Medication Compliance Scale (MCS), Holmes and Rahe Stress Scale (HRSS), Dysfunctional attitudes Scale 
(DAS), Toronto Alexithymia Scale (TAS-20), the Depression, Anxiety and Stress Scale (DASS-21) and 
Chaban Quality of Life Scale (CQLS)). Glycemic control was assessed by HbA1c results. 
The statistical analysis was performed using descriptive statistics and Pearson's correlation with MS Excel 
and SPSS Statistics 22.0. 
Results: A statistically significant difference was found between groups of patients with high (HC), middle 
(MC) and low level of compliance (LC) according to MCS. Patients with LC had statistically higher levels 
of HbA1c results according to MCS (LC (M=13), SD:1 vs. MC (M=9.83), SD:1.4 vs. HC (M=9), SD:1.4).  
Average values by MCS results for CG – DM1 (M=19) and DM2 (M=18) present MC; by HbA1c results – 
DM1 (M=10) and DM2 (M=10) at the same level. So, there was no significant statistical difference found 
between scores by the results in CG.  
A significant bilateral indirect correlation was found between the results by MCS (LC) with high level of the 
DAS, TAS-20, DASS-21, HRSS scores on level p<0,001 and direct by CQLS (r=0,37) results on 
p<0,01(HC). A relationship was also found between the scores by: 1) DAS (direct) – with the indicators of 
age, blood glucose level and depression, on level p<0,05, alexithymia, stress and anxiety (DASS-21) on 
p<0,01; 2) CQLS (indirect) – with the DAS (r=-0,28) and TAS-20 (r=-0,29) results – on p<0,05, stress (r=-
0,36) on p<0,01 and depression (DASS-21) (r=-0,48) on p<0,001; 3) TAS-20 (direct) – with the DASS-21 
subscales results on p<0,01. 
A strong relationship  was found between LC in DM patients with high level scores of psychometric scales 
and laboratory indicators of HbA1c, as evidenced, that patients with LC most often had mental disorders and 
low rates of treatment effectiveness. 
Conclusions: Adherence to treatment was not dependant on the type of diabetes and diagnosis. LC and 
quality of life added, in consequence, to non-adherence and, respectively, to the inefficiency of DM patients 
treatment. So, a multidisciplinary approach – involving psychologists for improving adherence to therapy 
together with endocrinology specialists, can potentially improve treatment effectiveness. 
Originality: The comparison of DM patients indicators by psychosocial status, demographic data and level 
of compliance, depending on the type of diabetes and diagnosis. 
Limitations of the study: The low sample of patients which is planned to be addressed in further studies. 
Strengths of the study: The concept of  ''adherence to treatment'' is much broader than the concept of 
"compliance", which is signified only by a strict adherence to the prescription of a doctor. Adherence to 
treatment – is a complex of the external and intrinsic factors of the patients’ environment and their 
characteristics as personalities, in relation to medical treatment. There is an extensive scope for studying and 
researching both in both clinical and social science fields. Multidisciplinary research would be a 
recommended approach for future research, because different specialists in their distinctive spheres may be  
able to unite with the common purpose of studying the problem of comorbidity. 
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